BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34389428)

  • 1. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
    Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
    Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
    Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
    Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroperitoneal histologic findings of patients with elevated serum alpha-fetoprotein and pure seminoma at orchiectomy.
    Kundu SD; Carver BS; Sheinfeld J
    Urology; 2011 Oct; 78(4):844-7. PubMed ID: 21782217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
    Peterson M; Beck S; Bihrle R; Einhorn L; Foster R
    BJU Int; 2009 Jul; 104(2):176-8. PubMed ID: 19493258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
    Iwatsuki S; Naiki T; Kawai N; Etani T; Iida K; Ando R; Nagai T; Okada A; Tozawa K; Sugiyama Y; Yasui T
    J Med Case Rep; 2016 May; 10(1):114. PubMed ID: 27150447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
    Kawai K; Kojima T; Miyanaga N; Hattori K; Hinotsu S; Shimazui T; Akaza H
    Int J Urol; 2005 Mar; 12(3):284-9. PubMed ID: 15828957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure Testicular Seminoma with Non-Pathologic Elevation of Alpha Fetoprotein: A Case Series.
    Dieckmann KP; Anheuser P; Simonsen H; Höflmayer D
    Urol Int; 2017; 99(3):353-357. PubMed ID: 28668957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
    Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
    J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant testicular seminoma.
    Ellimoottil C; Quek ML
    Urology; 2012 Oct; 80(4):e35-6. PubMed ID: 22901819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
    Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
    Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Trends in Presentation and Management of Spermatocytic Seminoma.
    Patel PM; Patel HD; Koehne EL; Doshi C; Belshoff A; Seffren CM; Baker M; Gorbonos A; Gupta G
    Urology; 2020 Dec; 146():177-182. PubMed ID: 33049234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of testicular seminoma with elevation of alpha fetoprotein. A case report].
    Durand X; Vedrine L; Deligne E; Desfemmes FR; Ceccaldi B; Houlgatte A
    Prog Urol; 2008 Mar; 18(3):190-2. PubMed ID: 18472076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.
    Spratt DE; Suresh K; Osawa T; Schipper M; Jackson WC; Abugharib A; Lebastchi A; Smith D; Montgomery JS; Palapattu GS; Priya Kunju L; Wu A; Lew M; Tomlins SA; Chinnaiyan AM; Weizer AZ; Hafez KS; Kaffenberger SD; Udager A; Mehra R
    Med Oncol; 2018 Jan; 35(3):21. PubMed ID: 29387987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
    Géczi L; Gomez F; Bak M; Bodrogi I
    J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-adapted treatment of clinical stage 1 non-seminoma testis cancer.
    Klepp O; Dahl O; Flodgren P; Stierner U; Olsson AM; Oldbring J; Nilsson S; Daehlin L; Tørnblom M; Småland R; Starkhammar H; Abramsson L; Wist E; Raabe N; Edekling T; Cavallin-Ståhl E
    Eur J Cancer; 1997 Jun; 33(7):1038-44. PubMed ID: 9376184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of a population based sample of men diagnosed with testicular cancer in the United States.
    Osswald M; Harlan LC; Penson D; Stevens JL; Clegg LX
    Urol Oncol; 2009; 27(6):604-10. PubMed ID: 18799329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
    Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
    Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is percent seminoma associated with intraoperative morbidity during post-chemotherapy RPLND?
    Russell CM; Sharma P; Agarwal G; Fisher JS; Richard GJ; Spiess PE; Pow-Sang JM; Poch MA; Sexton WJ
    Can J Urol; 2016 Feb; 23(1):8127-34. PubMed ID: 26892052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Clinicopathologic Study of 6 Patients with Histologically Pure Seminoma But Elevated Serum Alpha-Fetoprotein].
    Kandori S; Kawai K; Tanaka K; Kawahara T; Ikeda A; Ishitsuka R; Kimura T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
    Hinyokika Kiyo; 2017 Apr; 63(4):139-143. PubMed ID: 28506050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.